Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.13 - $12.03 $8,766 - $811,243
-67,435 Reduced 5.76%
1,102,375 $167,000
Q3 2022

Nov 14, 2022

BUY
$0.53 - $13.3 $1,536 - $38,556
2,899 Added 0.25%
1,169,810 $567,000
Q2 2022

Aug 12, 2022

BUY
$0.56 - $1.22 $7,560 - $16,470
13,500 Added 1.17%
1,166,911 $816,000
Q1 2022

May 13, 2022

BUY
$1.11 - $2.25 $66,049 - $133,884
59,504 Added 5.44%
1,153,411 $1.34 Million
Q4 2021

Feb 11, 2022

BUY
$1.35 - $4.89 $1.05 Million - $3.79 Million
775,599 Added 243.66%
1,093,907 $2.29 Million
Q3 2021

Nov 12, 2021

BUY
$0.67 - $3.41 $82,095 - $417,830
122,531 Added 62.59%
318,308 $483,000
Q2 2021

Aug 13, 2021

SELL
$2.11 - $4.93 $242,991 - $567,748
-115,162 Reduced 37.04%
195,777 $698,000
Q1 2021

May 12, 2021

BUY
$3.91 - $7.31 $629,189 - $1.18 Million
160,918 Added 107.26%
310,939 $1.48 Million
Q4 2020

Feb 12, 2021

BUY
$3.27 - $9.48 $306,513 - $888,607
93,735 Added 166.53%
150,021 $796,000
Q3 2020

Nov 13, 2020

BUY
$7.71 - $10.79 $203,682 - $285,050
26,418 Added 88.45%
56,286 $507,000
Q2 2020

Aug 13, 2020

BUY
$9.0 - $13.12 $268,812 - $391,868
29,868 New
29,868 $268,000

Others Institutions Holding BIOR

About BIORA THERAPEUTICS, INC.


  • Ticker BIOR
  • Exchange NASDAQ
  • Shares Outstandng 186,623,605
  • Market Cap $299M
  • Description
  • Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...
More about BIOR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.